SCHEMBL7798712

SCHEMBL7798712

CCOC(=O)C(/C=C/C(C)C)C(C)C(=O)O

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.34
ALDH1A1 P00352 3/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
LMNA P02545 1/20 0.32
HSD17B10 Q99714 1/20 0.32
PIN1 Q13526 1/20 0.32
ALOX15 P16050 1/20 0.31
MGAM O43451 1/20 0.31
GAA P10253 1/20 0.31
SI P14410 1/20 0.31
MGAM2 Q2M2H8 1/20 0.31
SOAT1 P35610 1/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8811455 0.81 HCAR2 (0.36) HCAR2ALDH1A1CYP2D6CYP2C19LMNA
SCHEMBL3934312 0.78 TP53 (0.35)
SCHEMBL5088264 0.77 HCAR2 (0.36) HCAR2ALDH1A1CYP2D6CYP2C9CYP2C19
SCHEMBL5088265 0.77 HCAR2 (0.36) HCAR2ALDH1A1CYP2D6CYP2C9CYP2C19
SCHEMBL3886255 0.74 ALDH1A1 (0.40) HCAR2ALDH1A1CYP2D6CYP2C9CYP2C19
SCHEMBL3886257 0.74 ALDH1A1 (0.40) HCAR2ALDH1A1CYP2D6CYP2C9CYP2C19
SCHEMBL10062279 0.74 ALDH1A1 (0.40) HCAR2ALDH1A1CYP2D6CYP2C9CYP2C19
SCHEMBL4757436 0.73 ALDH1A1 (0.43) HCAR2ALDH1A1LMNAHSD17B10PIN1
SCHEMBL15015691 0.73 ALDH1A1 (0.43) HCAR2ALDH1A1LMNAHSD17B10PIN1
SCHEMBL4757433 0.73 ALDH1A1 (0.43) HCAR2ALDH1A1LMNAHSD17B10PIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0830338-B1 Method of making 3-(aminomethyl)-5-methylhexanoic acid WARNER LAMBERT CO (US) 2001-12-12 EP disclosed
US-20010016665-A1 METHOD OF MAKING (S)-3-(AMINOMETHYL) -5- METHYLHEXANOIC ACID GROTE TODD MICHEL (US) 2001-08-23 US disclosed
US-6046353-A Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid WARNER-LAMBERT COMPANY (US) 2000-04-04 US disclosed
US-5840956-A Method of making (S)-3-(Aminomethyl)-5-Methylhexanoic acid WARNER-LAMBERT COMPANY (US) 1998-11-24 US disclosed
US-5637767-A Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid WARNER-LAMBERT COMPANY (US) 1997-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010016665-A1 METHOD OF MAKING (S)-3-(AMINOMETHYL) -5- METHYLHEXANOIC ACID APEH, CA6, ALKBH3 HCAR2 170/4885ALDH1A1 316/4885CYP2D6 775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.